These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1989154)

  • 1. Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent.
    Küchle CC; Thoenes GH; Langer KH; Schorlemmer HU; Bartlett RR; Schleyerbach R
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1083-6. PubMed ID: 1989154
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides.
    Schorlemmer HU; Schwab W; Ruuth E; Kurrle R
    Transplant Proc; 1996 Dec; 28(6):3048-50. PubMed ID: 8962182
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivative.
    Schorlemmer HU; Seiler FR; Bartlett RR
    Transplant Proc; 1993 Feb; 25(1 Pt 1):763-7. PubMed ID: 8438472
    [No Abstract]   [Full Text] [Related]  

  • 4. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of mouse-to-rat skin xenograft rejection by malononitrilamides.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1996 Dec; 28(6):3037-9. PubMed ID: 8962179
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
    Xiao F; Chong A; Foster P; Sankary H; McChesney L; Williams JM; Frieders D; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive effects of leflunomide in a cardiac allograft model.
    Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465
    [No Abstract]   [Full Text] [Related]  

  • 9. An evaluation of leflunomide in the canine renal transplantation model.
    McChesney LP; Xiao F; Sankary HN; Foster PF; Sharma S; Haklin M; Williams JW
    Transplantation; 1994 Jun; 57(12):1717-22. PubMed ID: 8016874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
    Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H
    Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
    Williams JW; Xiao F; Foster P; Clardy C; McChesney L; Sankary H; Chong AS
    Transplantation; 1994 Apr; 57(8):1223-31. PubMed ID: 8178350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM
    Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperacute skin allograft rejection in presensitized rats is abrogated by malononitrilamides.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1998 Jun; 30(4):963-7. PubMed ID: 9636390
    [No Abstract]   [Full Text] [Related]  

  • 16. Additive effects of leflunomide and tacrolimus in prevention of islet xenograft rejection.
    Zhang L; Qi Z; Wu D; Shan S; Ekberg H
    Scand J Immunol; 2004 Mar; 59(3):255-60. PubMed ID: 15030575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extending the survival time of allogenic rat kidney transplants by PUVA treatment of the recipient].
    Oesterwitz H; Gruner S; Schneider W
    Z Urol Nephrol; 1990 Jan; 83(1):13-6. PubMed ID: 2330760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Female sex hormone, estradiol, antagonizes the immunosuppressive activity of cyclosporine in rat organ transplantation.
    Hirasawa K; Kamada N
    Transplant Proc; 1992 Feb; 24(1):408-9. PubMed ID: 1311480
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of ATG for reversal of acute allograft rejection.
    Nowygrod R; Appel G; Hardy MA
    Transplant Proc; 1981 Mar; 13(1 Pt 1):469-72. PubMed ID: 7022875
    [No Abstract]   [Full Text] [Related]  

  • 20. Leflunomide. Arava, HWA 486, SU 101.
    Drugs R D; 1999 Jan; 1(1):87-91. PubMed ID: 10565997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.